Zymeworks Inc. (NYSE: ZYME) kicked off on August 04, 2022, at the price of $6.28, up 5.59% from the previous trading day. During the day, the shares moved up to $6.61 and dropped to $6.27 before settling in for the closing price of $6.26. Over the past 52 weeks, ZYME has traded in a range of $4.56-$37.19.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
A company in the Healthcare sector has jumped its sales by 19.40% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -14.70%. With a float of $48.33 million, this company’s outstanding shares have now reached $61.37 million.
In an organization with 327 employees, it is important to assess its efficiency.
Zymeworks Inc. (ZYME) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zymeworks Inc. is 0.10%, while institutional ownership is 90.00%. The most recent insider transaction that took place on Mar 10, was worth 20,496. In this transaction Chief Operating Officer of this company sold 2,979 shares at a rate of $6.88, taking the stock ownership to the 13,276 shares. Before that another transaction happened on Jan 07, when Company’s Chief Medical Officer bought 5,000 for $14.28, making the entire transaction worth $71,386. This insider now owns 7,119 shares in total.
Zymeworks Inc. (ZYME) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 3/30/2022, the organization reported -$1.18 earnings per share (EPS), higher than consensus estimate (set at -$1.67) by $0.49. This company achieved a net margin of -794.01 while generating a return on equity of -64.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.91 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.00% during the next five years compared to -9.10% drop over the previous five years of trading.
Zymeworks Inc. (NYSE: ZYME) Trading Performance Indicators
Take a look at Zymeworks Inc.’s (ZYME) current performance indicators. Last quarter, stock had a quick ratio of 4.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.43, a number that is poised to hit -0.96 in the next quarter and is forecasted to reach -2.87 in one year’s time.
Technical Analysis of Zymeworks Inc. (ZYME)
Let’s dig in a bit further. During the last 5-days, its volume was 0.75 million. That was inferior than the volume of 1.41 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 81.48%. Additionally, its Average True Range was 0.41.
During the past 100 days, Zymeworks Inc.’s (ZYME) raw stochastic average was set at 61.75%, which indicates a significant decrease from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.13% in the past 14 days, which was lower than the 96.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.10, while its 200-day Moving Average is $10.44. However, in the short run, Zymeworks Inc.’s stock first resistance to watch stands at $6.72. Second resistance stands at $6.84. The third major resistance level sits at $7.06. If the price goes on to break the first support level at $6.38, it is likely to go to the next support level at $6.16. Assuming the price breaks the second support level, the third support level stands at $6.04.
Zymeworks Inc. (NYSE: ZYME) Key Stats
The company with the Market Capitalisation of 383.84 million has total of 57,771K Shares Outstanding. Its annual sales at the moment are 26,680 K in contrast with the sum of -211,843 K annual income. Company’s last quarter sales were recorded 1,920 K and last quarter income was -72,630 K.